Gabapentin Capsule
Product Images NDC 71610-631

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 400 mg (71610 0631 53)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Image 01)

This is a tabular representation of the mean pain score data with respect to dose titration and fixed dose period of Parkod (drug). The study examines the impact of Gabapentin (at a dosage of 3600 mg/day) and placebo on pain reduction. The Mean Pain Score is presented for each week during baseline and the course of the study (up to week 4). The scan may have missed some detail.*

FDA Label Image

Figure 2 (Image 02)

This is a graph showing the results of a study where participants were given a placebo, gabapentin at 1800 mg/day, or gabapentin at 2400 mg/day over a period of 4 weeks. The graph shows the mean pain score at baseline and each week during the study.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.